ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. Assignors: CAI, JIANFENG Publication of US20170101439A1 publication Critical patent/US20170101439A1/en Assigned to H. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201461984179P priority Critical Priority to PCT/US2015/027801 priority patent/WO2015164870A1/en Application filed by University of South Florida, H Lee Moffitt Cancer Center and Research Institute Inc filed Critical University of South Florida Priority to US15/332,402 priority patent/US10000531B2/en Assigned to UNIVERSITY OF SOUTH FLORIDA reassignment UNIVERSITY OF SOUTH FLORIDA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee University of South Florida H Lee Moffitt Cancer Center and Research Institute Inc Priority date (The priority date is an assumption and is not a legal conclusion. H Lee Moffitt Cancer Center and Research Institute Inc Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Sebti Jianfeng Cai Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US15/332,402 Other versions US20170101439A1 Google Patents US10000531B2 - Gamma-AA-peptide STAT3/DNA inhibitors and methods of use US10000531B2 - Gamma-AA-peptide STAT3/DNA inhibitors and methods of use
0 kommentar(er)
